Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases by Jinli Li, Yang Li, Guangtao Song, Haiying Wang, Qing Zhang, Min Wang, Muxue Zhao, Bei Wang, HuiGuo Zhu, Liu Ranzhi, Qiang Wang, Yuyan Xiong

Subjects: Get full text

Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018 by Yan Jiang, Yingying Shen

Subjects: Get full text

Cardiovascular risk factors, global cardiovascular risk, and vascular age in a cohort of Peruvian HIV patients by German Valenzuela-Rodriguez, Jaime A. Collins, Raul Castillo, Luis R. Illescas, Adrian V. Hernandez, Carlos Diaz-Arocutipa

Subjects: “…cardiovascular risk…”
Get full text

Impact of Diabetes on Cardiovascular Disease: An Update by Alessandra Saldanha de Mattos Matheus, Lucianne Righeti Monteiro Tannus, Roberta Arnoldi Cobas, Catia C. Sousa Palma, Carlos Antonio Negrato, Marilia de Brito Gomes

“…Cardiovascular diseases are the most prevalent cause of morbidity and mortality among patients with type 1 or type 2 diabetes. …”
Get full text

Editorial: Women in lipids in cardiovascular disease by Irena Levitan, Catherine Martel, Catherine Martel

“…Frontiers in Cardiovascular Medicine…”
Get full text

Cardiovascular Risk Factors in the Antiphospholipid Syndrome by Felipe Freire da Silva, Roger Abramino Levy, Jozélio Freire de Carvalho

“…Therefore, the clinical and laboratory investigation of comorbidities known to increase cardiovascular risk in patients with antiphospholipid antibody syndrome is crucial for the adoption of a more complete and effective treatment. …”
Get full text

Lung cancer and risk of cardiovascular mortality by Chengshi Wang, Zhu Wang, Jing Yang, Songbo Zhang, Purong Zhang, Ye Yang

Subjects: Get full text

ABO Blood Groups and Cardiovascular Diseases by Hanrui Zhang, Ciarán J. Mooney, Muredach P. Reilly

“…ABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. …”
Get full text

Editorial: Hemodynamic parameters and cardiovascular changes by Tania Pereira, Tania Pereira, Kais Gadhoumi, Ran Xiao

Subjects: Get full text

Visfatin/Nampt: An Adipokine with Cardiovascular Impact by Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró

“…Moreover, visfatin/Nampt circulating levels correlate with markers of systemic inflammation. In cardiovascular diseases, visfatin/Nampt was initially proposed as a clinical marker of atherosclerosis, endothelial dysfunction, and vascular damage, with a potential prognostic value. …”
Get full text

Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases by Ricky Patil, Hui Wang, Matthew Kazaleh, Gorav Ailawadi, Morgan Salmon

Get full text

Adult ADHD Medications and Their Cardiovascular Implications by A. Sinha, O. Lewis, R. Kumar, S. L. H. Yeruva, B. H. Curry

“…Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the etiology of rare cardiovascular events like acute myocardial infarction (AMI), arrhythmia, and cardiomyopathy and its long-term sequelae. …”
Get full text

Study of Gender in Sudden Cardiovascular Death by Rafael Emilio Araujo González, Luis Alberto Ochoa Montes, Rubén Herrera Masó, Mileidys González Lugo, Nidia Doris Tamayo Vicente, Daisy Ferrer Marrero

Subjects: “…enfermedades cardiovasculares…”
Get full text

The Impact of Bioactive Lipids on Cardiovascular Development by Alexander Kleger, Stefan Liebau, Qiong Lin, Götz von Wichert, Thomas Seufferlein

“…In this paper we will focus on the differential and developmental impact of lysophospholipids on cardiovascular development.…”
Get full text

Hypertension in the High-Cardiovascular-Risk Populations by Samy I. McFarlane, Girardin Jean-Louis, Ferdinand Zizi, Adam T. Whaley-Connell, Olugbenga Ogedegbe, Amgad N. Makaryus, Ilir Maraj

Get full text

Cardiovascular rehabilitation. Results in the cardiology service. by Juan José Navarro López, Roberto S. Vega Hernández., Claudio González Rodríguez., Teresa Rodríguez Rodríguez

Subjects: Get full text

PPAR Agonists and Cardiovascular Disease in Diabetes by Anna C. Calkin, Merlin C. Thomas

“…In recent clinical trials, PPAR𝛼 agonists have been shown to be effective in the primary prevention of cardiovascular events, while their cardiovascular benefit in patients with established cardiovascular disease remains equivocal. …”
Get full text

Riesgo cardiovascular en mujeres sanas by Mildrey Jiménez López, Carlos Jorge Hidalgo Mesa, Ivonne Cepero Rodríguez, Sarait Rojas Hernández, Niurka Milagros Ortiz Madrazo

Subjects: Get full text

Cardiovascular manifestations in COVID-19 patients by Jyotsna Maddury, Mani Krishna, Achukatla Kumar

“…Preexisting conditions, such as cardiovascular disease (CVD), hypertension, diabetes, and obesity, increase the severity as well as mortality rate of COVID. …”
Get full text

Association of Activity and Inertia for Cardiovascular Health by Keji CHEN

Subjects: “…cardiovascular disease…”
Get full text